Janssen Discontinues Development of Flubendazole Formulation to Treat Onchocerciasis
Research supported Johnson& Johnson ’s commitment to the 2012 London Declaration on Neglected Tropical Diseases and yielded important findings
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | River Blindness